THYROID-ASSOCIATED OPHTHALMOPATHY WITH SUSPECTED SECONDARY GLAUCOMA

Authors

  • Marie Yuni Andari Department of Ophthalmology, Faculty of Medicine, University of Mataram/West Nusa Tenggara
  • Pandu Ishaq Nandana Department of Urology, Faculty of Medicine, University of Mataram/West Nusa Tenggara
  • Jessica Paramitha Aritonang Medical Profession Study Program, Faculty of Medicine, University of Mataram, Indonesia General Hospital, Lombok, Indonesia

DOI:

https://doi.org/10.29303/jk.v11i2.4674

Keywords:

Thyroid-associated ophthalmopathy, secondary glaucoma, Grave’s Disease, steroid

Abstract

Introduction: Thyroid-associated ophthalmopathy (TAO) is a thyroid hormone imbalance that manifests in the eye. The most common TAO is in Grave’s Disease. TAO could increase the intraocular pressure and could cause a glaucoma optic neuropathy and therefore secondary glaucoma could happen. We are reporting a 26 years old male came to the West Nusa Tenggara Eye Clinic both eyes bulging since 10 months ago. This patient’s complain happens with red eyes, dirt around the eyelashes, pain around the eye, feeling tired, heart beats faster, and no weight gain. This patient came again after not taking his usual medicine for one month.Based on the eyes examination, this patient had lagophthalmos and proptosis on both eyes, palpebra oedema, hyperaemia on tarsal conjunctiva, conjunctiva injection, corneal infiltrate, limited eyeball movement for both eyes, and increased intraocular pressure. The laboratory result shows hyperthyroid and head CT scan shows medial lateral rectus muscle hypertrophy. This patient was given timolol maleate eye drop 0,5% and levofloxacin eye drop 0,5%.Early identification of the diagnosis and controlled therapy of TAO could prevent the secondary glaucoma.

Downloads

Published

2022-06-30

Issue

Vol. 11 No. 2 (2022): Jurnal Kedokteran

Section

Articles

License

Authors who publish with Unram Medical Journal, agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine. 
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  4. This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.